Page last updated: 2024-09-02

kt 5823 and tetraethylammonium

kt 5823 has been researched along with tetraethylammonium in 1 studies

Compound Research Comparison

Studies (kt 5823)	Trials (kt 5823)	Recent Studies (post-2010) (kt 5823)	Studies (tetraethylammonium)	Trials (tetraethylammonium)	Recent Studies (post-2010) (tetraethylammonium)
317	0	59	3,877	10	298

Protein Interaction Comparison

Protein	Taxonomy	kt 5823 (IC50)	tetraethylammonium (IC50)
Solute carrier family 22 member 1	Mus musculus (house mouse)		0.54
Solute carrier family 22 member 2	Mus musculus (house mouse)		3.5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Archer, S; Cornfield, DN; Reeve, HL; Tolarova, S; Weir, EK	1

Other Studies

1 other study(ies) available for kt 5823 and tetraethylammonium

Article	Year
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proceedings of the National Academy of Sciences of the United States of America, 1996, Jul-23, Volume: 93, Issue:15 Topics: Alkaloids; Aminoquinolines; Animals; Carbazoles; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Female; Fetus; Glyburide; Guanylate Cyclase; Hypoxia; Indoles; Isoquinolines; Membrane Potentials; Models, Cardiovascular; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Potassium Channels; Pregnancy; Protein Kinase Inhibitors; Pulmonary Artery; Sheep; Sulfonamides; Tetraethylammonium; Tetraethylammonium Compounds; Vasodilation	1996

Article

Year

Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel.

Proceedings of the National Academy of Sciences of the United States of America, 1996, Jul-23, Volume: 93, Issue:15

Topics: Alkaloids; Aminoquinolines; Animals; Carbazoles; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Female; Fetus; Glyburide; Guanylate Cyclase; Hypoxia; Indoles; Isoquinolines; Membrane Potentials; Models, Cardiovascular; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Potassium Channels; Pregnancy; Protein Kinase Inhibitors; Pulmonary Artery; Sheep; Sulfonamides; Tetraethylammonium; Tetraethylammonium Compounds; Vasodilation

1996